Icici Prudential Asset Management CO LTD Seagen Inc. Transaction History

Icici Prudential Asset Management CO LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$191.51 - $216.16 $75,837 - $85,599	396 Added 31.08%	1,670 $354,000
Q2 2023 Jul 20, 2023	BUY	$187.64 - $206.25 $14,635 - $16,087	78 Added 6.52%	1,274 $245,000
Q1 2023 May 04, 2023	BUY	$127.59 - $203.08 $33,683 - $53,613	264 Added 28.33%	1,196 $242,000
Q4 2022 Feb 07, 2023	BUY	$117.37 - $139.17 $29,929 - $35,488	255 Added 37.67%	932 $119,000
Q3 2022 Oct 28, 2022	BUY	$135.27 - $180.11 $17,314 - $23,054	128 Added 23.32%	677 $93,000
Q2 2022 Aug 05, 2022	BUY	$108.81 - $179.33 $2,393 - $3,945	22 Added 4.17%	549 $98,000
Q1 2022 May 09, 2022	BUY	$119.61 - $157.85 $9,090 - $11,996	76 Added 16.85%	527 $75,000
Q4 2021 Feb 08, 2022	BUY	$142.57 - $190.86 $64,299 - $86,077	451 New	451 $70,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Icici Prudential Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Icici Prudential Asset Management CO LTD with notifications on news.